BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34477998)

  • 21. T cell phenotypes in patients with common variable immunodeficiency disorders: associations with clinical phenotypes in comparison with other groups with recurrent infections.
    Bateman EA; Ayers L; Sadler R; Lucas M; Roberts C; Woods A; Packwood K; Burden J; Harrison D; Kaenzig N; Lee M; Chapel HM; Ferry BL
    Clin Exp Immunol; 2012 Nov; 170(2):202-11. PubMed ID: 23039891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Classical ataxia telangiectasia patients have a congenitally aged immune system with high expression of CD95.
    Carney EF; Srinivasan V; Moss PA; Taylor AM
    J Immunol; 2012 Jul; 189(1):261-8. PubMed ID: 22649200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reference ranges of lymphocyte subsets in healthy adults and adolescents with special mention of T cell maturation subsets in adults of South Florida.
    Valiathan R; Deeb K; Diamante M; Ashman M; Sachdeva N; Asthana D
    Immunobiology; 2014 Jul; 219(7):487-96. PubMed ID: 24661720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoglobulins in ataxia-telangiectasia: evidence for IgG4 and IgA2 subclass deficiencies.
    Rivat-Peran L; Buriot D; Salier JP; Rivat C; Dumitresco SM; Griscelli C
    Clin Immunol Immunopathol; 1981 Jul; 20(1):99-110. PubMed ID: 6973438
    [No Abstract]   [Full Text] [Related]  

  • 25. Serum IgG subclass deficiency in ataxia-telangiectasia.
    Aucouturier P; Bremard-Oury C; Griscelli C; Berthier M; Preud'homme JL
    Clin Exp Immunol; 1987 May; 68(2):392-6. PubMed ID: 3652519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ataxia-telangiectasia patients presenting with hyper-IgM syndrome.
    Noordzij JG; Wulffraat NM; Haraldsson A; Meyts I; van't Veer LJ; Hogervorst FB; Warris A; Weemaes CM
    Arch Dis Child; 2009 Jun; 94(6):448-9. PubMed ID: 19224889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunologic aspects of West syndrome and evidence of plasma inhibitory effects on T cell function.
    Montelli TC; Soares AM; Peraçoli MT
    Arq Neuropsiquiatr; 2003 Sep; 61(3B):731-7. PubMed ID: 14595474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective deficiency of CD4+/CD45RA+ lymphocytes in patients with ataxia-telangiectasia.
    Paganelli R; Scala E; Scarselli E; Ortolani C; Cossarizza A; Carmini D; Aiuti F; Fiorilli M
    J Clin Immunol; 1992 Mar; 12(2):84-91. PubMed ID: 1373152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T and B lymphocyte subpopulations and activation/differentiation markers in patients with selective IgA deficiency.
    Litzman J; Vlková M; Pikulová Z; Stikarovská D; Lokaj J
    Clin Exp Immunol; 2007 Feb; 147(2):249-54. PubMed ID: 17223965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [IgG and IgA deficiency with hyper IgM].
    Rodríguez Cuartero A; García Vera E
    Rev Clin Esp; 1993 Feb; 192(2):97-8. PubMed ID: 8460250
    [No Abstract]   [Full Text] [Related]  

  • 31. Different clinical and laboratory evolutions in ataxia-telangiectasia syndrome: report of four cases.
    Forte WC; Menezes MC; Dionigi PC; Bastos CL
    Allergol Immunopathol (Madr); 2005; 33(4):199-203. PubMed ID: 16045857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous granulomas in ataxia telangiectasia and other primary immunodeficiencies: reflection of inappropriate immune regulation?
    Chiam LY; Verhagen MM; Haraldsson A; Wulffraat N; Driessen GJ; Netea MG; Weemaes CM; Seyger MM; van Deuren M
    Dermatology; 2011; 223(1):13-9. PubMed ID: 21876338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoglobulin production in Epstein-Barr virus-transformed lymphoblastoid cell lines in patients with ataxia telangiectasia.
    Ariga T; Sakiyama Y; Matsumoto S; Okano M; Osato T
    Int Arch Allergy Appl Immunol; 1985; 78(1):33-6. PubMed ID: 2993170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of B cell subsets in primary immune deficiencies that progress with antibody deficiency and age-matched healthy children.
    Celiksoy MH; Yildiran A
    Allergol Immunopathol (Madr); 2016; 44(4):331-40. PubMed ID: 26976550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum IgD concentrations in patients with ataxia telangiectasia and with selective IgA deficiency.
    Sanal O; Ozaltin F; Tezcan I; Ersoy F
    Int Arch Allergy Immunol; 1998 Jul; 116(3):246. PubMed ID: 9696048
    [No Abstract]   [Full Text] [Related]  

  • 36. Ataxia-telangiectasia in Iran: clinical and laboratory features of 104 patients.
    Moin M; Aghamohammadi A; Kouhi A; Tavassoli S; Rezaei N; Ghaffari SR; Gharagozlou M; Movahedi M; Purpak Z; Mirsaeid Ghazi B; Mahmoudi M; Farhoudi A
    Pediatr Neurol; 2007 Jul; 37(1):21-8. PubMed ID: 17628218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B-cell subsets in patients with transient hypogammaglobulinemia of infancy, partial IgA deficiency, and selective IgM deficiency.
    Cipe FE; Doğu F; Güloğlu D; Aytekin C; Polat M; Biyikli Z; Ikincioğullari A
    J Investig Allergol Clin Immunol; 2013; 23(2):94-100. PubMed ID: 23654075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The defect in humoral immunity in patients with Nijmegen breakage syndrome is explained by defects in peripheral B lymphocyte maturation.
    Piątosa B; van der Burg M; Siewiera K; Pac M; van Dongen JJ; Langerak AW; Chrzanowska KH; Bernatowska E
    Cytometry A; 2012 Oct; 81(10):835-42. PubMed ID: 22851427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thymic and bone marrow output in patients with common variable immunodeficiency.
    Serana F; Airò P; Chiarini M; Zanotti C; Scarsi M; Frassi M; Lougaris V; Plebani A; Caimi L; Imberti L
    J Clin Immunol; 2011 Aug; 31(4):540-9. PubMed ID: 21491094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of Specific Antibody Responses in Patients with Selective IgA Deficiency and Ataxia Telangiectasia.
    Khanmohammadi S; Shad TM; Delavari S; Shirmast P; Bagheri Y; Azizi G; Aghamohammadi A; Abolhassani H; Yazdani R; Rezaei N
    Endocr Metab Immune Disord Drug Targets; 2022; 22(6):640-649. PubMed ID: 35135457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.